Back to Home Page of CD3WD Project or Back to list of CD3WD Publications

CLOSE THIS BOOKFact sheet No 103: Ebola Haemorrhagic Fever - Revised December 2000 (WHO, 2000, 3 p.)
VIEW THE DOCUMENT(introduction...)
VIEW THE DOCUMENTTransmission
VIEW THE DOCUMENTTherapy
VIEW THE DOCUMENTContainment
VIEW THE DOCUMENTContacts
VIEW THE DOCUMENTHistory and Prevalence
VIEW THE DOCUMENTNatural Reservoir

Therapy

· No specific treatment or vaccine exists for Ebola haemorrhagic fever.

· Severe cases require intensive supportive care, as patients are frequently dehydrated and in need of intravenous fluids.

· Experimental studies involving the use of hyper-immune sera on animals demonstrated no long-term protection against the disease after interruption of therapy.

TO PREVIOUS SECTION OF BOOK TO NEXT SECTION OF BOOK